The Québec NTBC Study-Reference-Cited by-同舟云学术

The Québec NTBC Study

Published:2017 Issue: Volume: Page:187-195
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Alvarez Fernando, ,Atkinson Suzanne,Bouchard Manon,Brunel-Guitton Catherine,Buhas Daniela,Bussières Jean-François,Dubois Josée,Fenyves Daphna,Goodyer Paul,Gosselin Martyne,Halac Ugur,Labbé Patrick,Laframboise Rachel,Maranda Bruno,Melançon Serge,Merouani Aicha,Mitchell Grant A.,Mitchell John,Parizeault Guy,Pelletier Luc,Phan Véronique,Turcotte Jean-François

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-55780-9_17

Reference6 articles.

1. Grompe M, St-Louis M, Demers SI, Al-Dhalimy M, Leclerc B, Tanguay RM (1994) A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N Engl J Med 331(6):353–357. doi: 10.1056/NEJM199408113310603

2. Hall MG, Wilks MF, Provan WM, Eksborg S, Lumholtz B (2001) Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers. Br J Clin Pharmacol 52(2):169–177

3. Larochelle J, Alvarez F, Bussieres JF, Chevalier I, Dallaire L, Dubois J, Faucher F, Fenyves D, Goodyer P, Grenier A, Holme E, Laframboise R, Lambert M, Lindstedt S, Maranda B, Melancon S, Merouani A, Mitchell J, Parizeault G, Pelletier L, Phan V, Rinaldo P, Scott CR, Scriver C, Mitchell GA (2012) Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Quebec. Mol Genet Metab 107(1–2):49–54. doi: 10.1016/j.ymgme.2012.05.022

4. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340(8823):813–817

5. Mitchell G, Larochelle J, Lambert M, Michaud J, Grenier A, Ogier H, Gauthier M, Lacroix J, Vanasse M, Larbrisseau A et al (1990) Neurologic crises in hereditary tyrosinemia. N Engl J Med 322(7):432–437. doi: 10.1056/NEJM199002153220704

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vivo dissection of the mouse tyrosine catabolic pathway with CRISPR-Cas9 identifies modifier genes affecting hereditary tyrosinemia type 1;GENETICS;2024-08-23

2. Hepatocellular carcinoma in an infant with tyrosinemia type 1;Česko-slovenská pediatrie;2023-06-23

3. Simultaneous succinylacetone-nitisinone measurement in tyrosinemia type I patients and evaluation of nitisinone therapeutic range;2022-12-20

4. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions;Nature Communications;2022-08-25

5. Liver Transplantation: A Safe and Definitive Alternative to Lifelong Nitisinone for Tyrosinemia Type 1;Indian Journal of Pediatrics;2021-08-16